EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices

Joshua Walker iD, Amsajini Ravinthiranathan, Athanasios Diamantopoulos iD, Spyridon Gennatas iD, Alexandros Georgiou iD

Current Oncology · 2025

DOI: 10.3390/curroncol32110601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Joshua Walker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guy's and St Thomas' NHS Trust, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK. Hauptthemen laut MEDLINE: Anticoagulants, Stents, Superior Vena Cava Syndrome, Endovascular Procedures. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: A knowledge gap persists regarding anticoagulation therapy after endovascular stent insertion for malignant superior vena cava obstruction (mSVCO). Guidelines are supported by retrospective studies with a radiological focus and lack specific drug recommendations. No studies to date have captured the multi-disciplinary nature of decision-making over time.

Methods

This single-center retrospective service evaluation includes patients with solid organ malignancy who received a stent for mSVCO between July 2016 and May 2022. Patient and treatment characteristics, clinical outcomes and prescribing decisions were collected from medical records and analyzed.

Results

Of 49 patients (55% female, mean age 59), 73% had metastatic extra-thoracic disease at stent insertion. Technical success was achieved in 98% of cases and 92% survived to discharge. Forty-eight patients were followed until death. Median survival was 2.4 months. Post-procedure imaging (performed in 55% of patients) revealed 10 (21%) cases of systemic venous thromboembolism and 7 cases of stent thrombosis. Forty-four (91%) patients received anticoagulation therapy (62% therapeutic dose low molecular weight heparin). Those with thrombotic complications were fitter pre-procedurally than the rest of the cohort. There was one case of major bleeding. Twenty-two instances of therapy modification occurred following the initial plan, including nine changes due to a patient preference for oral therapy.

Conclusion

Patients undergoing stenting for mSVCO demonstrate high thrombotic risk and a poor prognosis. Anticoagulation plans are frequently modified post discharge due to changing risk profiles and patient preferences. Multi-disciplinary collaboration is essential to support patient-centered and individualized management. Future research should investigate direct oral anticoagulants and anti-platelet therapy and develop risk assessment tools for this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsStentsSuperior Vena Cava SyndromeEndovascular ProceduresNeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultAged, 80 and over

Stichwörter der Autor:innen

SVCOVTEanticoagulationendovascular stentmalignant superior vena cava obstructionpulmonary embolismstent-thrombosissuperior vena cava syndromethrombosisvenous thromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Guy's and St Thomas' NHS Trust, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Campus, Great Maze Pond, London SE1 1UL, UK.

ORCID-Profile: Joshua Walker, Athanasios Diamantopoulos, Spyridon Gennatas, Alexandros Georgiou

Zitieren

APA

Walker, J., Ravinthiranathan, A., Diamantopoulos, A., Gennatas, S., & Georgiou, A. (2025). A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices. Current Oncology. https://doi.org/10.3390/curroncol32110601

Vancouver

Walker J, Ravinthiranathan A, Diamantopoulos A, Gennatas S, Georgiou A. A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices. Current Oncology. 2025. doi:10.3390/curroncol32110601

BibTeX
@article{Walker2025,
  author = {Walker, Joshua and Ravinthiranathan, Amsajini and Diamantopoulos, Athanasios and Gennatas, Spyridon and Georgiou, Alexandros},
  title = {A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32110601}
}
Kostenlos starten →